期刊文献+

高剂量左氧氟沙星注射液治疗临床常见细菌感染的疗效和安全性评价 被引量:5

Evaluation of the efficacy and safety of high dose levofloxacin in management of common bacterial infections
下载PDF
导出
摘要 目的评价高剂量(500mg,1次d)左氧氟沙星注射液治疗临床常见细菌感染的有效性和安全性。方法采用前瞻性、开放、多中心研究方法在浙江地区8所医院共纳入各种细菌感染333例和术后预防感染患者70例,各系统平均疗程(5.72±3.20)d。结果左氧氟沙星注射液500mgd,1次d给药治疗常见细菌感染的临床有效率为92.49%,细菌清除率为91.67%,临床不良反应发生率为5.71%,主要为轻度胃肠道反应和注射部位发红、发痒等刺激性表现。结论高剂量左氧氟沙星注射液(500mgd,1次d)治疗临床常见细菌感染性疾病,疗效好,安全性高。 Objective To evaluate the efficacy and safety of high dose levofloxacin (LVFX) in management of common bacterial infections. Methods A prospective, multiple-center, open clinical trial was conducted. Three hundred and thirty three patients with bacterial infections and 70 postoperative patients from 8 hospitals in Zhejiang Province were enrolled. Average duration of LVFX (500mg LV. per day) administration was 3.63-8.01 days. Results The total clinical efficacy was 92.49% and the eradication rate was 91.67%. Safety assessment showed that clinical adverse reactions were 5.71%, mainly were mild gastrointestinal and local irritatire reactions. Conclusion LVFX administration at 500mg per day is effective in the treatment of bacterial infections with high tolerance and safety.
作者 俞云松
出处 《浙江医学》 CAS 2006年第2期91-92,95,共3页 Zhejiang Medical Journal
关键词 左氧氟沙星 细菌感染 临床研究 Levofloxacin Bacterial infections Clinical trial
  • 相关文献

参考文献7

  • 1File TM Jr,Segreti J,Dunbar L,et al.A multicenter,randomized study comparing the safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in the treatment of adults with community-acquired pneumonia[J].Antimicrob Agents Chemoth,1997,41:1965-1972.
  • 2Marrie TJ.Experience with levofloxacin in critical pathway for the treatment of community-acquired pneumonia[J].Chemotherapy,2004,50 (Suppl 1):11-15.
  • 3Frank E,Liu J,Kinasewitz G,Moran GJ,et al.A multicenter open-label,randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia[J].Clin Ther,2002,24:1292-1308.
  • 4Mandell LA,Bartlett JG,Dowell SF,et al.Infectious Diseases Society of America.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults[J].Clin Infect Dis,2003,37:1405-1433.
  • 5Bartlett JG,Dowell SF,Mandell LA,et al.Practice guidelines for the management of community-acquired pneumonia in adults.Infectious Diseases Society of America[J].Clin Infect Dis,2000,31:347-382.
  • 6Ball P.Efficacy and safety of levofloxacin in the context of other contemporary fluroquinolones:A review.Current Therapeutic Research[J].2003,64:646-661.
  • 7Hurst M,Lamb HM,Scott L J,et al.Levofloxacin:An updated review of its use in the treatment of bacterial infections[J].Drugs,2002,62:2127-2167.

同被引文献28

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部